Drug Profile
Ancestim biosimilar - Profarma
Alternative Names: PF-09; Recombinant human stem cell factor - Profarma; Recombinant SCF - ProfarmaLatest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator Profarma
- Class Antianaemics; Antineoplastics; Stem cell factors
- Mechanism of Action Colony stimulating factor stimulants; Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for research development in Cancer in Lithuania (Parenteral)
- 17 Jun 2015 Early research in Cancer in Lithuania (Parenteral) (Profarma pipeline, June 2015)
- 02 Apr 2015 Profarma has patent protection for ancestim biosimilar (Profarma website, June 2015)